The rising prevalence of brain disorder such as Parkinson’s disease to boost the Electroencephalographs Market growth

 

Electroencephalographs Market

Electroencephalographs Market is segmented by Product Type (Magnetoencephalograph, Electroencephalograph, Cerebral Oximeters, Functional Magnetic Resonance Imaging (fMRI), Intracranial Pressure Monitoring Devices, and Other Product Types), Application (Parkinson’s Disease, Traumatic Brain Injury, Epilepsy, Dementia, Sleep Disorders, and Other Applications), End User (Hospitals, and Diagnostic Centers) , and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- - Size, Share, Outlook, and Opportunity Analysis, 2023 – 2030

The global Electroencephalographs Market is estimated to be valued at US$ XX million in XXX and is expected to exhibit a CAGR of XX% over the forecast period, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Electroencephalograph is a device is used for recording the activity of electrical signals in the brain. It is executed by fixing electrodes on the skin which covers the top part of the head and signals are sent to a particular device. An Electroencephalograph may be utilized to analyze brain and sleep diseases. Electroencephalograph in short is also known as EEG.

Competitive Landscape:

Key players involved in the global electroencephalograph market are Neurosoft CamNtech Ltd, HEYER Medical AG, Medicom MTD, NeuroWave Systems Inc., Draeger, Inc., MT MonitorTechnik GmbH & CO.KG Natus Medical Incorporated, Brain Products, elmiko medical, Danmeter, and Masimo.

Market Key Drivers:

The rising prevalence of brain disorder such as Parkinson’s disease is expected to augment the growth of the global electroencephalographs market. For instance, as per WHO, around 9.4 million suffer from Parkinson’s disease across the globe.

The rising cases of Alzheimer’s disease is projected to propel the growth of the global electroencephalographs market. For instance, as per NCBI around 24 million people globally are affected with Alzheimer’s disease.

Covid-19 Impact Analysis:

The Covid-19 outbreak has adversely affected the growth of the global electroencephalographs market. The rise in the pandemic cases has led to delay in other check-ups and hospital visits. The rising shift of doctors to diagnose the Covid-19 patients led to the shortage of physicians in the healthcare centers. The imposition of strict lockdown has also impeded the market growth.

Key Takeaways:

The global electroencephalographs market is expected to exhibit a CAGR of XX % during the forecast period due to rising mental illness. For instance, as per MHA, around 19.86% suffer from mental disorders. 

Among region North America, Asia Pacific and Europe are anticipated to witness robust growth in the global electroencephalographs market due to rising neurological disorders such as epilepsy, Parkinson’s disease, Alzheimer’s disease and narcolepsy. For instance, as per WHO, 1.2% of the U.S population actively suffer from epilepsy.